Ginkgo Bioworks Holdings Inc vs Genuine Parts Company — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Genuine Parts Company trades at $135.22 (market cap $18.62B). The key difference: Genuine Parts Company is far larger — about 36.8× Ginkgo Bioworks Holdings Inc's market cap, and Genuine Parts Company pays a 3.15% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | GPC | |
|---|---|---|
Market Cap | $505.73M | $18.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $16.14 | $149.26 |
52-Week Low | $5.48 | $92.47 |
Enterprise Value | $607.68M | $24.72B |
Dividend Yield | — | 3.15% |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →